Australia markets closed

CryoLife, Inc. (CRY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
22.61+0.02 (+0.09%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5884.5M
Enterprise value 31.14B
Trailing P/E N/A
Forward P/E 164.60
PEG ratio (5-yr expected) 143.05
Price/sales (ttm)3.49
Price/book (mrq)2.68
Enterprise value/revenue 34.49
Enterprise value/EBITDA 741.07

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 314.66%
S&P500 52-week change 349.51%
52-week high 326.60
52-week low 316.13
50-day moving average 323.89
200-day moving average 322.13

Share statistics

Avg vol (3-month) 3179.76k
Avg vol (10-day) 3168.63k
Shares outstanding 539.12M
Implied shares outstanding 6N/A
Float 37.2M
% held by insiders 13.73%
% held by institutions 184.27%
Shares short (14 Mar 2021) 43.74M
Short ratio (14 Mar 2021) 422.75
Short % of float (14 Mar 2021) 412.11%
Short % of shares outstanding (14 Mar 2021) 49.56%
Shares short (prior month 11 Feb 2021) 43.79M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.03
Trailing annual dividend yield 30.13%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Dec 2015
Ex-dividend date 408 Dec 2015
Last split factor 23:2
Last split date 327 Dec 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin -6.59%
Operating margin (ttm)2.75%

Management effectiveness

Return on assets (ttm)0.62%
Return on equity (ttm)-5.43%

Income statement

Revenue (ttm)253.23M
Revenue per share (ttm)6.69
Quarterly revenue growth (yoy)-2.60%
Gross profit (ttm)167.78M
EBITDA 27.68M
Net income avi to common (ttm)-16.57M
Diluted EPS (ttm)-0.44
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)61.41M
Total cash per share (mrq)1.58
Total debt (mrq)317.37M
Total debt/equity (mrq)96.55
Current ratio (mrq)3.88
Book value per share (mrq)8.45

Cash flow statement

Operating cash flow (ttm)12.37M
Levered free cash flow (ttm)6.31M